PRE-CONFERENCE TRANSATLANTIC REGULATORY BRIEFING –
Transatlantic Regulatory Insight: Opportunities for Strategic Life Sciences Investment in the U.S., UK, and EU
(Refreshments will be served)

Chris Boyle, Meenakshi Datta, Maarten Meulenbelt, Josefine Sommer, Rebecca Wood, Sidley

WELCOME

Tom Thesing, Managing Partner, Sidley

OPENING REMARKS

Dan Mahony, Chair Biotech Industry Association and Senior Partner, Novo Holdings 

David Probert, Chief Executive, University College London Hospital, and Deputy Chief Executive, NHS England

THE PHARMA BUSINESS DEVELOPMENT ENVIRONMENT – OPINIONS, INSIGHTS, AND PREDICTIONS FROM LEADING DEALMAKERS

MODERATOR: Asher Rubin, Partner, Sidley

SPEAKERS:

Caroline Austin, PhD, Vice-President and Head of Transactions UK, AstraZeneca

Susanna El-Armale, Chief Corporate Development Officer, Advanz Pharma

Evan Lippman, Executive Vice-President, Business Development, Teva Pharmaceuticals

Matthias Muellenbeck, SVP, Head Global Business Development & Alliance Management, Merck KGaA

FIRESIDE CHAT – A DISCUSSION ABOUT THE WORK OF THE CLINTON HEALTH ACCESS INITIATIVE, AND ITS UNIQUE ROLE AT THE NEXUS OF GOVERNMENT, BUSINESS, AND HEALTH

MODERATOR: Robert Darwin, Partner, Sidley

SPEAKERS:

Chelsea Clinton, DPhil, MPH, Vice Chair, Clinton Foundation, Clinton Health Access Initiative

“THE SUCCESS JOURNEY” – CEOs WHO HAVE ACHIEVED OUTSIZED SUCCESS DISCUSS THEIR WINNING FORMULAE

MODERATOR: Dr. Annalisa Jenkins, M.B.B.S., F.R.C.P.,
Non-Executive Director, LetterOne

SPEAKERS:

Susan Hill, Chief Executive Officer, Mestag Therapeutics

Dr. Jeremy Levin, Chairman and Chief Executive Officer, Ovid Therapeutics

Catherine Pickering, CEO, iOnctura

Sam Waksal, PhD, Founder and Chief Executive Officer, Graviton Bioscience

“VIEW FROM THE BANKS” – THE YEAR PASSED, AND TO COME, IN HEALTHCARE DEALMAKING

MODERATOR: Hannah Kuchler, Global Pharmaceutical Editor, Financial Times

SPEAKERS:

Stefano Beschi, Partner, Rothschild & Co.

Henry Capper, Managing Director, J.P. Morgan

Michael Margolis, R.Ph., Senior Managing Director, Oppenheimer & Co. Inc.

James Talbot, Managing Director, Morgan Stanley

VENTURE/GROWTH CAPITAL – HOW DO LEADING INVESTORS VIEW THE CURRENT MARKET? HOW DO INVESTORS STAND OUT?

MODERATOR: Geoff Levin, Partner, Sidley

SPEAKERS: 

Katya Smirnyagina, Senior Partner, Oxford Science Enterprises

Ed Hodgkin, Managing Partner, Syncona

Laura Lane, VP, Head of European Venture, Lilly Ventures

PRIVATE EQUITY – INVESTING IN HEALTHCARE IN TURBULENT MARKETS

MODERATOR: Jay Sadanandan, Partner, Sidley

SPEAKERS:

Bastien Hermans, Managing Director, Mid-Cap, Astorg

Chris LiPuma, Managing Director, Fortress

Stefan Linn, Managing Director, LetterOne Health

CLOSING REMARKS

Hutan Ashrafian, Chief Scientific Officer, Harbinger Health